Clinical Trials Search

Title Intervention NCT IDsort descending Sponsor Status
Reproductive Health Program in Patients With Cancer educational intervention, quality-of-life assessment, questionnaire administration NCT01806129 Eastern Cooperative Oncology Group Active, not recruiting
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) anastrozole, questionnaire administration, laboratory biomarker analysis, pharmacogenomic studies NCT01824836 Eastern Cooperative Oncology Group Active, not recruiting
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In... metformin hydrochloride, placebo NCT01905046 Alliance for Clinical Trials in Oncology Recruiting
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Metformin, Placebo NCT02028221 University of Arizona Active, not recruiting
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Pamidronate, Calcium and vitamin D NCT02074631 Masonic Cancer Center, University of Minnesota Recruiting
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer Adaptation of IMCP for Chinese Immigrant Cancer Patients, In-depth Patient Interviews, Individual Meaning-Centered Psychotherapy for Chinese (IMCP-Ch) (For Phase 3) NCT02112188 Memorial Sloan Kettering Cancer Center Recruiting
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline NCT02134925 National Cancer Institute (NCI) Active, not recruiting
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Quality-of-Life Assessment, Questionnaire Administration, Placebo Administration NCT02237183 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 International Breast Cancer Study Group Active, not recruiting

Pages